Brentuximab
Modify Date: 2024-10-11 17:51:56
Brentuximab structure
|
Common Name | Brentuximab | ||
|---|---|---|---|---|
| CAS Number | 2088770-90-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BrentuximabBrentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies[1]. |
| Name | Brentuximab |
|---|
| Description | Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Oh Y, et al. Part II: Prognosis and management. J Am Acad Dermatol. 2021 Nov;85(5):1093-1106. |
| No Any Chemical & Physical Properties |